Construction and detection of the tissue-specific pINV-HPV16 e6/7 vector

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 857-862

  Gao, Hui ^a   Huang, Zhengfang ^a   Shi, Chenlong ^a   Li, Houda ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

E6 7; Human papilloma viruses; pINV HPV16 E6 7; Tissue specificity

Indexed keywords

GENOMIC DNA; INVOLUCRIN; PROTEIN E6; PROTEIN E7;

ADULT; ARTICLE; CLINICAL ARTICLE; CLONING VECTOR; GEL ELECTROPHORESIS; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; UTERINE CERVIX CARCINOMA;

EID: 84918771814     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2736     Document Type: Article

References (19)

1. Al-Hendy A, Magliocco AM, Al-Tweigeri T, Braileanu G, et al: Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol 182: 553-559, 2000.
2. Stoff-Khalili MA, Dall P and Curiel DT: Gene therapy for carcinoma of the breast. Cancer Gene Ther 13: 633-647, 2006.
3. Das S, E1-Deiry WS and Somasundaram K: Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73beta. Oncogene 22: 8394-8402, 2003.
4. Gu W, Putral L, Hengst K, et al: Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther 13: 1023-1032, 2006.
5. Alencar TR, Cerqueira DM, da Cruz MR, et al: New HPV-16 European and non-European variants in central Brazil. Virus Genes 35: 1-4, 2007.
6. Kim DH, Kim EM, Lee EH, et al: Human papillomavirus 16E6 suppresses major histocompatibility complex class I by upregulating lymphotoxin expression in human cervical cancer cells. Biochem Biophys Res Commun 409: 792-798, 2011.
7. Scheffner M and Whitaker NJ: Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol 13: 59-67, 2003.
8. Song S, Liem A, Miller JA and Lambert PF: Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267: 141-50, 2000.
9. Liu Y, McKalip A and Herman B: Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. J Cell Biochem 78: 334-349, 2000.
10. Tran NQ and Crowe DL: Regulation of the human involucrin gene promoter by co-activator proteins. Biochem J 381: 267-273, 2004.
11. Tzvetkov MV, Meineke C, Oetijen E, Hirsch-Ernst K and Brockmöller J: Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine. Gene 386: 52-62, 2007.
12. Crish JF and Eckert RL: Synergistic activation of human involucrin gene expression by Fra-1 and p300 - evidence for the presence of a multiprotein complex. J Invest Dermatol 128: 530-541, 2008.
13. Adhikary G, Crish J, Lass J and Eckert RL: Regulation of involucrin expression in normal human corneal epithelial cells: a role for activator protein one. Invest Ophthalmol Vis Sci 45: 1080-1087, 2004.
14. Kasparek P, Krenek P, Buryova H, et al: Transgenic mouse model expressing tdTomato under involucrin promoter as a tool for analysis of epidermal differentiation and wound healing. Transgenic Res 21: 683-689, 2012.
15. Clifford GM, Smith JS, Plummer M, Muñoz N and Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73, 2003.
16. Porto CR, De Oliveira Kleine JP, Longatto Filho A and Da Silva ID: Polymorphism of Interleukin-6 is not associated with the presence or absence of high HPV E6/E7. Anticancer Res 34: 3501-3504, 2014.
17. Miller J, Dakic A, Chen R, Palechor-Ceron N, et al: HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. PLoS Pathog 9: e1003284, 2013.
18. Zhou J, Li B, Peng C, et al: Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes. Antiviral Res 98: 305-313, 2013.
19. Weiming Z, Yong X, Deling K, et al: Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer. Urol Oncol 27: 539-547, 2009.